NantOmics to Report Data on Cardiac Function in Sarcoma Patients Receiving Aldoxorubicin with Doxorubicin Equivalent Doses Over 1000 mg/m2 at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

by Jen Hodson | Jun 2, 2018 | Press Releases

Results to be presented during the sarcoma session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 2, 2018 – NantWorks, LLC today announced that its affiliate company, NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of...

NantOmics to Present Analysis on Potential Therapeutic Target in Adenoid Cystic Carcinoma at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

by Jen Hodson | Jun 2, 2018 | Press Releases

Results to be presented during the head and neck cancer session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 2, 2018 – NantWorks, LLC today announced that its affiliate company, NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks...

NantOmics Announces Study Showing Signature Analysis that Reveals Three Distinct Classifications of Skin Cancer Known as Sebaceous Carcinoma

by Jen Hodson | May 21, 2018 | Press Releases

May 21, 2018 Research published on May 14 in the peer-reviewed journal Nature Communications shows for the first time three distinct classifications of sebaceous carcinoma, a rare and sometimes deadly form of skin cancer. Culver City, CA – May 21, 2018 – NantOmics,...

SNN: Breakthrough Cancer Treatment Targets Each Patient’s Unique Tumor

by Jen Hodson | Feb 17, 2017 | Press Releases

February 17,...

Genos Names Four Research Partners, Launches Sequencing Platform

by Jen Hodson | Dec 16, 2016 | Press Releases

December 16, 2016 a GenomeWeb staff reporter NEW YORK (GenomeWeb) – Consumer genomics firm Genos announced yesterday named four of its research partners, which are using the company’s newly launched whole-exome sequencing platform in various projects and...